Regarding Il-1β involvement in synaptic pathology associated with AD, IL1-ra treatment partially attenuated Aβ1–40 impairment of LTP in the CA1 of hippocampus [30], supporting previous findings suggesting that Aβ1–40 induces the release of IL-1β [74]. This evidence concerns the gene IL1B and Alzheimer disease.